Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31–46.

CAS  PubMed  Google Scholar 

Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7:286.

CAS  PubMed  PubMed Central  Google Scholar 

Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187:235–56.

CAS  PubMed  Google Scholar 

Christgen S, Tweedell RE, Kanneganti T-D. Programming inflammatory cell death for therapy. Pharmacol Ther. 2022;232:108010.

CAS  PubMed  Google Scholar 

Rogers C, Fernandes-Alnemri T, Mayes L, Alnemri D, Cingolani G, Alnemri ES. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun. 2017;8:14128.

CAS  PubMed  PubMed Central  Google Scholar 

Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7:196.

PubMed  PubMed Central  Google Scholar 

Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15:174.

PubMed  PubMed Central  Google Scholar 

Wei X, Xie F, Zhou X, Wu Y, Yan H, Liu T, et al. Role of pyroptosis in inflammation and cancer. Cell Mol Immunol. 2022;19:971–92.

CAS  PubMed  PubMed Central  Google Scholar 

Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395–417.

PubMed  PubMed Central  Google Scholar 

Malireddi RKS, Kesavardhana S, Kanneganti T-D. ZBP1 and TAK1: master regulators of NLRP3 inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019;9:406.

CAS  PubMed  PubMed Central  Google Scholar 

Kuriakose T, Man SM, Malireddi RKS, Karki R, Kesavardhana S, Place DE, et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol. 2016;1:aag2045.

Pandian N, Kanneganti T-D. PANoptosis: a unique innate immune inflammatory cell death modality. J Immunol. 2022;209:1625–33.

CAS  PubMed  Google Scholar 

Lin J-F, Hu P-S, Wang Y-Y, Tan Y-T, Yu K, Liao K, et al. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Signal Transduct Target Ther. 2022;7:54.

CAS  PubMed  PubMed Central  Google Scholar 

Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti T-D. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature. 2021;597:415–9.

CAS  PubMed  PubMed Central  Google Scholar 

Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184:149–68.

Lin C, Lin P, Yao H, Liu S, Lin X, He R, et al. Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer. Cancer Lett. 2024;587:216712.

CAS  PubMed  Google Scholar 

Tan Y-T, Li T, Wang R-B, Liu Z-K, Ma M-Y, Huang R-Z, et al. WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis. Cancer Lett. 2024;604:217254.

CAS  PubMed  Google Scholar 

Zhang Z, Zhang F, Pang P, Li Y, Chen X, Sun S, et al. Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma. Front Cell Dev Biol. 2023;11:1210456.

PubMed  PubMed Central  Google Scholar 

Wang X, Sun R, Chan S, Meng L, Xu Y, Zuo X, et al. PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer. Front Genet. 2022;13:955355.

CAS  PubMed  PubMed Central  Google Scholar 

Yi X, Li J, Zheng X, Xu H, Liao D, Zhang T, et al. Construction of PANoptosis signature: novel target discovery for prostate cancer immunotherapy. Mol Ther Nucleic Acids. 2023;33:376–90.

CAS  PubMed  PubMed Central  Google Scholar 

Hänggi K, Li J, Gangadharan A, Liu X, Celias DP, Osunmakinde O, et al. Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity. Cancer Cell. 2024;42:2015–31.

Wang X, Guo X, Ren H, Song X, Chen L, Yu L, et al. An “Outer Piezoelectric and Inner Epigenetic” logic-gated PANoptosis for osteosarcoma sono-immunotherapy and bone regeneration. Adv Mater. 2025;37:e2415814.

PubMed  Google Scholar 

Oh S, Lee J, Oh J, Yu G, Ryu H, Kim D, et al. Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis. Cell Mol Immunol. 2023;20:1513–26.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang T, Yin C, Fedorov A, Qiao L, Bao H, Beknazarov N, et al. ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis. Nature. 2022;606:594–602.

CAS  PubMed  PubMed Central  Google Scholar 

Christgen S, Zheng M, Kesavardhana S, Karki R, Malireddi RKS, Banoth B, et al. Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:237.

CAS  PubMed  PubMed Central  Google Scholar 

Karki R, Sharma BR, Lee E, Banoth B, Malireddi RKS, Samir P, et al. Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight. 2020;5:e136720.

Kuriakose T, Kanneganti T-D. ZBP1: innate sensor regulating cell death and inflammation. Trends Immunol. 2018;39:123–34.

CAS  PubMed  Google Scholar 

Liu K, Wang M, Li D, Duc Duong NT, Liu Y, Ma J, et al. PANoptosis in autoimmune diseases interplay between apoptosis, necrosis, and pyroptosis. Front Immunol. 2024;15:1502855.

CAS  PubMed  PubMed Central  Google Scholar 

Kesavardhana S, Malireddi RKS, Burton AR, Porter SN, Vogel P, Pruett-Miller SM, et al. The Zα2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development. J Biol Chem. 2020;295:8325–30.

CAS  PubMed  PubMed Central  Google Scholar 

Zhan J, Wang J, Liang Y, Wang L, Huang L, Liu S, et al. Apoptosis dysfunction: unravelling the interplay between ZBP1 activation and viral invasion in innate immune responses. Cell Commun Signal. 2024;22:149.

CAS  PubMed  PubMed Central  Google Scholar 

Karki R, Lee S, Mall R, Pandian N, Wang Y, Sharma BR, et al. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci Immunol. 2022;7:eabo6294.

CAS  PubMed  Google Scholar 

Lou J, Mao Y, Jiang W, Shen H, Fan Y, Yu Q, et al. TRIM56 modulates YBX1 degradation to ameliorate ZBP1-mediated neuronal PANoptosis in spinal cord injury. Adv Sci. 2024;11:e2407132.

Google Scholar 

Li J, Jia Y-C, Lu J, Zhang H, Wang Z, Xie X, et al. Inhibition of Zbp1-PANoptosome-mediated PANoptosis effectively attenuates acute pancreatitis. Cell Death Discov. 2025;11:180.

CAS  PubMed  PubMed Central  Google Scholar 

Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol. 2009;10:266–72.

PubMed  Google Scholar 

Ma C, Li S, Hu Y, Ma Y, Wu Y, Wu C, et al. AIM2 controls microglial inflammation to prevent experimental autoimmune encephalomyelitis. J Exp Med. 2021;218:e20201796.

Coll RC, Schroder K. Inflammasome components as new therapeutic targets in inflammatory disease. Nat Rev Immunol. 2025;25:22–41.

CAS  PubMed  Google Scholar 

Cassel SL, Joly S, Sutterwala FS. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol. 2009;21:194–8.

CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Zhai H, Alemayehu H, Boulanger J, Hopkins LJ, Borgeaud AC, et al. Cryo-electron tomography of NLRP3-activated ASC complexes reveals organelle co-localization. Nat Commun. 2023;14:7246.

CAS  PubMed  PubMed Central  Google Scholar 

Paik S, Kim JK, Shin HJ, Park E-J, Kim IS, Jo E-K. Updated insights into the molecular networks for NLRP3 inflammasome activation. Cell Mol Immunol. 2025;22:563–96.

CAS  PubMed  PubMed Central  Google Scholar 

Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183:787–91.